Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma.

Christoph RoderburgSven Heiko LoosenJan BednarschPatrick H AlizaiAnjali A RoethSophia M SchmitzMihael VucurMark LueddePia PaffenholzFrank TackeChristian TrautweinTom F UlmerUlf Peter NeumannTom Luedde

Published in: International journal of molecular sciences (2021)

Circulating PD-L1 levels were decreased in patients with resectable BTC. Lack of normalization of PD-L1 levels after surgery might identify patients at high risk for tumor recurrence or adverse outcome.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
locally advanced
electronic health record